Oral Macrocyclic Peptide Inhibitors of Cytokine Signaling
- Macrocyclic peptides derived from display-based technologies occupy the intermediate chemical space between small molecules and antibodies
- Chemical matter optimization strategies using structure-guided designs and non-canonical amino acids deliver drug-like leads
- Antibody-like biological activity can be achieved in blocking cytokine signaling implicated in immune-mediated diseases